Safety of endoscopy in cancer patients on antiangiogenic agents: A retrospective multicenter outcomes study.

Safety of endoscopy in cancer patients on antiangiogenic agents: A retrospective multicenter outcomes study.

The use of antiangiogenic agents (AAs) in cancer treatment has increased because they offer survival benefit in combination with cytotoxic chemotherapy. Given their potential to cause gastrointestinal (GI) perforation and bleeding, it is currently recommended that AAs be held for 28 days before and...

Full description

Bibliographic Details
Main Authors:	Toufic Kachaamy, Digant Gupta, Persis Edwin, Pankaj Vashi
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2017-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC5417598?pdf=render

Similar Items

Methylmalonic Acid and Homocysteine as Indicators of Vitamin B-12 Deficiency in Cancer.
by: Pankaj Vashi, et al.
Published: (2016-01-01)

Renal Cell Carcinoma with Unusual Metastasis to the Small Intestine Manifesting as Extensive Polyposis: Successful Management with Intraoperative Therapeutic Endoscopy
by: Pankaj G. Vashi, et al.
Published: (2011-08-01)

Incidence of and factors associated with catheter-related bloodstream infection in patients with advanced solid tumors on home parenteral nutrition managed using a standardized catheter care protocol
by: Pankaj G. Vashi, et al.
Published: (2017-05-01)

Multicenter study on the safety of bariatric endoscopy
by: Eduardo Espinet-Coll, et al.

Angiogenesis and antiangiogenic agents in cervical cancer
by: Tomao F, et al.
Published: (2014-12-01)

Role of nutritional status in predicting quality of life outcomes in cancer – a systematic review of the epidemiological literature
by: Lis Christopher G, et al.
Published: (2012-04-01)

Role of antiangiogenic agents in the treatment of metastatic colorectal cancer
by: M. V. Zabelin, et al.
Published: (2018-05-01)

Antiangiogenic agents from tripterygium wilfordii for cancer treatment.
Published: (2009)

Clinicopathological features and outcome of esophageal neuroendocrine tumor: A retrospective multicenter survey by the digestive endoscopy society of Taiwan
by: I-Chen Wu, et al.
Published: (2021-01-01)

Colon Carcinoma with Unusual Metastasis to the Esophagus Manifesting as Multiple Nodules and Dysphagia: Management with Systemic Chemotherapy
by: Pankaj G. Vashi, et al.
Published: (2012-07-01)

Safety profiles of current antiangiogenic therapies for metastatic colorectal cancer
by: Fuloria J
Published: (2012-08-01)

Pulmonary cavitation in patients with thyroid cancer receiving antiangiogenic agents
by: Saumil Datar, et al.
Published: (2020-12-01)

Serum 25-hydroxyvitamin D is inversely associated with body mass index in cancer
by: Braun Donald P, et al.
Published: (2011-05-01)

Longitudinal monitoring of CA125 levels provides additional information about survival in ovarian cancer
by: Gupta Digant, et al.
Published: (2010-10-01)

Multicenter retrospective evaluation of ileocecocolic perforations associated with diagnostic lower gastrointestinal endoscopy in dogs and cats
by: Vanessa L. Woolhead, et al.
Published: (2020-03-01)

PPARα Ligands as Antitumorigenic and Antiangiogenic Agents
by: Ambra Pozzi, et al.
Published: (2008-01-01)

The association between pre-treatment serum 25-hydroxyvitamin D and survival in newly diagnosed stage IV prostate cancer.
by: Digant Gupta, et al.
Published: (2015-01-01)

Medium-term outcomes of sacral neuromodulation in patients with refractory overactive bladder: A retrospective single-institution study.
by: Bilal Kaaki, et al.
Published: (2020-01-01)

Combination antiangiogenic tyrosine kinase inhibition and anti‐PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomes
by: Andrew L. Laccetti, et al.
Published: (2021-04-01)

Patient safety in an endoscopy unit: an observational retrospective analysis of reported incidents
by: Cora Salles Maruri Correa, et al.
Published: (2021-03-01)

Antiangiogenic treatment in hepatocellular carcinoma: the balance of efficacy and safety
by: Welker MW, et al.
Published: (2013-10-01)

Risk profile for antiangiogenic agent-related osteonecrosis of the jaws
by: Raquel D’Aquino Garcia Caminha, et al.

The effects of antiangiogenic agents upon the coagulation and angiogenic systems
by: Nash, Guy Fairbairn
Published: (2003)

Sarcopenia supersedes subjective global assessment as a predictor of survival in colorectal cancer.
by: Pankaj G Vashi, et al.
Published: (2019-01-01)

Efficacy and safety of lenvatinib in combination with everolimus in metastatic renal cell carcinoma resistant to antiangiogenic targeted therapy: Russian multicenter observational study ROSLERCM
by: M. I. Volkova, et al.
Published: (2019-10-01)

Fucoidan/Tat peptide self-assembled nanoparticles as an antiangiogenic agent development in metastatic cancer
by: Lyu, Ya-Chi, et al.
Published: (2019)

Melatonin as an Adjuvant to Antiangiogenic Cancer Treatments
by: Alicia González, et al.
Published: (2021-06-01)

Radiotherapy and Antiangiogenic TM in Lung Cancer
by: Mohamed K. Khan, et al.
Published: (2002-01-01)

Modulation of Immunity by Antiangiogenic Molecules in Cancer
by: Magali Terme, et al.
Published: (2012-01-01)

Antiangiogenic Steroids in Human Cancer Therapy
by: Richard J. Pietras, et al.
Published: (2005-01-01)

A retrospective matched cohort study evaluating the effects of percutaneous endoscopic gastrostomy feeding tubes on nutritional status and survival in patients with advanced gastroesophageal malignancies undergoing systemic anti-cancer therapy.
by: Scott Mitchell, et al.
Published: (2017-01-01)

A retrospective matched cohort study evaluating the effects of percutaneous endoscopic gastrostomy feeding tubes on nutritional status and survival in patients with advanced gastroesophageal malignancies undergoing systemic anti-cancer therapy
by: Mitchell, Scott, et al.
Published: (2017)

Can subjective global assessment of nutritional status predict survival in ovarian cancer?
by: Gupta Digant, et al.
Published: (2008-10-01)

Antiangiogenic therapy
by: Avitabile T
Published: (2010-05-01)

Modern aspects of antiangiogenic therapy in ovarian cancer
by: A. A. Rumyantsev, et al.
Published: (2018-11-01)

Interaction between Immunotherapy and Antiangiogenic Therapy for Cancer
by: Koichi Furukawa, et al.
Published: (2020-08-01)

Antiangiogenic gene therapy of cancer: recent developments
by: Libutti Steven K, et al.
Published: (2004-06-01)

Antiangiogenic mechanisms and factors in breast cancer treatment
by: Jessica M Castañeda-Gill, et al.
Published: (2016-01-01)

Antiangiogenic effects of oridonin
by: Lili Tian, et al.
Published: (2017-04-01)

Antiangiogeneic Strategies in Mesothelioma
by: Anna K. Nowak, et al.
Published: (2020-02-01)